2016 BCOP Recertification

Upcoming Events


Check out the latest edition of HOPA News!

HOPA News Volume 15 issue 4

Latest Discussions

HOPA Bulletin

  • Infants with stage 4S neuroblastoma usually have favorable outcomes with observation or minimal chemotherapy. However, young infants with symptoms secondary to massive hepatomegaly or with unfavorable tumor biology are at high risk of death. Our aim was to improve outcomes for patients with symptomatic and/or unfavorable biology 4S neuroblastoma with a uniform treatment approach using a biology- and response-based algorithm.

Getting Started

Check out our user guide for further information.

Connect With Us